- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Joseph McEvoy Outlines Barriers to Mitigating Internal Stigma Surrounding Mental Illness
The core feature of internalized stigma is shame, and it leads to avoidance of treatment or help for patients with mental illness, explained Joseph McEvoy, MD, professor of psychiatry and health behavior, Medical College of Georgia.
The core feature of internalized stigma is shame, and it leads to avoidance of treatment or help, explained Joseph McEvoy, MD, professor of psychiatry and health behavior, Medical College of Georgia.
Transcript
What are the biggest barriers to mitigating internal stigma surrounding mental illness?
The core feature of internalized stigma is shame. People have accepted harsh judgments, beliefs about themselves and internalized them. And one of the biggest barriers is that this leads to avoidance, and they don’t seek treatment or help, which might include efforts to engage them more in social groups, in activities and peer support, and other ways to get them more social contact to get more people around them who say, ”We like you. You matter to us. You’re worth something.”
Efforts to give them some productive activity, be it volunteer work, be it sheltered workshop, be it supportive employment and periods of work and competitive employment. The most grinding, the most problematic aspect of internalized stigma and the shame it brings is this avoidance. A failure to seek out others, to hide. A failure which leads to a failure to get the support you need to get out of internalized stigma. Now, some people on the basis of feeling stigma, may go into actual depression, and they lose energy, they lose initiative, they lose the ability to push through and do what needs to be done for them to feel better. And, they may need pharmacologic or psychosocial treatment for that.
But, I think, the biggest problem with internalized stigma is letting people get alienated, letting people get isolated, and taking them away from the contacts they need to build up some stigma resistance, to understand they have value, to understand they can lead productive lives, they can have social contacts, they can be happy. They have this mental illness, it wasn’t their fault, they didn’t cause it. We can manage it and they can do the things they want to do.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
